CRVS
Corvus Pharmacet (CRVS)
NASDAQ
$10.67+$0.61 (+6.12%)
Price as of Oct 22, 2026 7:42 PM EDT
  • $845.4M
    Market Cap
  • 39.97%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 25
Valuation
CRVS
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 21
Valuation
CRVS
vs History
vs S&P 500
3-Month Momentum
-7.12%
12-Month Momentum
86.67%
3-Month Risk Adjusted Momentum
-35.50%
12-Month Risk Adjusted Momentum
48.80%

True Yield

N/A
Valuation
CRVS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 33
Valuation
CRVS
vs History
vs S&P 500
Ohlson's O-Score
1